About the Authors

Nicholas I. Brodie

Contributed equally to this work with: Nicholas I. Brodie, Konstantin I. Popov

Roles Investigation, Writing – original draft

Affiliation University of Victoria -Genome British Columbia Proteomics Centre, Vancouver Island Technology Park, Victoria, British Columbia, Canada

Konstantin I. Popov

Contributed equally to this work with: Nicholas I. Brodie, Konstantin I. Popov

Roles Investigation, Methodology, Writing – review & editing

Affiliation Department of Biochemistry and Biophysics, University of North Carolina, Chapel Hill, North Carolina, United States of America

Evgeniy V. Petrotchenko

Roles Conceptualization, Methodology, Supervision, Writing – review & editing

Current address: Segal Cancer Proteomics Centre, Lady Davis Institute, Jewish General Hospital, McGill University, Quebec, Canada

Affiliations University of Victoria -Genome British Columbia Proteomics Centre, Vancouver Island Technology Park, Victoria, British Columbia, Canada, Segal Cancer Proteomics Centre, Lady Davis Institute, Jewish General Hospital, McGill University, Quebec, Canada

Nikolay V. Dokholyan

Roles Conceptualization, Funding acquisition, Methodology, Software, Supervision, Writing – review & editing

dokh@psu.edu (NVD); christoph@proteincentre.com (CHB)

Affiliations Department of Biochemistry and Biophysics, University of North Carolina, Chapel Hill, North Carolina, United States of America, Departments of Pharmacology, and Biochemistry and Molecular Biology, Pennsylvania State College of Medicine, Hershey, Pennsylvania, United States of America

Christoph H. Borchers

Roles Conceptualization, Funding acquisition, Methodology, Supervision, Writing – review & editing

dokh@psu.edu (NVD); christoph@proteincentre.com (CHB)

Affiliations University of Victoria -Genome British Columbia Proteomics Centre, Vancouver Island Technology Park, Victoria, British Columbia, Canada, Segal Cancer Proteomics Centre, Lady Davis Institute, Jewish General Hospital, McGill University, Quebec, Canada, Department of Biochemistry and Microbiology, University of Victoria, Victoria, British Columbia, Canada, Gerald Bronfman Department of Oncology, Jewish General Hospital, McGill University, Montreal, Quebec, Canada

Competing Interests

I have read the journal’s policy and the authors of this manuscript have the following competing interests: CHB is the CSO of MRM Proteomics, Inc. CHB and EVP are co-founders of Creative Molecules, Inc.